A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) should be considered as an option for individuals with type 1 diabetes who want ...

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular disease (CVD) and diabetic kidney disease (DKD) in overweight and obese (OW/OB ...

NextCell Pharma AB ("NextCell" or "the Company") announces that the last patient in the older age cohort (12-21 years) of the clinical Phase II study, ProTrans-Young, has now completed their 12-month ...

Your body shows early signs of future diabetes risk. Learn to spot these subtle clues and take action before it becomes a ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

February was heart months, and this is another column in a series about the major risk factors for heart attacks. According ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss the importance of how monitoring your blood sugar levels regularly is important for managing diabetes and how new research shows that ...

The class will include a delicious meal along with real-life applications to help participants make healthier choices for ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...